$52.85
-0.12-0.23%
Pre-Market: 5:54 AM EDT
Comments
Loading...
Rhythm Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RYTM | Benzinga
Rhythm Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.710
Quarterly Revenue Estimate
$39.07M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$130.13M
Analyze the earnings history of Rhythm Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Rhythm Pharmaceuticals (RYTM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-0.72 | $-0.73 | 1.37 % |
| Q3 | 2024-11-05 | $-0.73 | $-0.80 | 8.75 % |
| Q2 | 2024-08-06 | $-0.55 | $-0.71 | 22.5 % |
| Q1 | 2024-05-07 | $-2.35 | $-2.16 | -8.80 % |
Rhythm Pharmaceuticals (RYTM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $41.83M | $38.48M | 8.71 % |
| Q3 | 2024-11-05 | $33.25M | $32.52M | 2.25 % |
| Q2 | 2024-08-06 | $29.08M | $29.29M | -0.72 % |
| Q1 | 2024-05-07 | $25.97M | $26.90M | -3.47 % |
FAQ
When is Rhythm Pharmaceuticals (NASDAQ:RYTM) reporting earnings?
Rhythm Pharmaceuticals (RYTM) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Rhythm Pharmaceuticals (NASDAQ:RYTM)?
The Actual EPS was $-0.72, which beat the estimate of $-0.73.
What were Rhythm Pharmaceuticals’s (NASDAQ:RYTM) revenues?
The Actual Revenue was $41.8M, which beat the estimate of $38.5M.
Browse earnings estimates, EPS, and revenue on all stocks.